Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Cancer. 2002 Apr 22;86(8):1270-5.

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.

Author information

  • 1Department of Medicine II, Leipzig University, Philipp-Rosenthal-Str. 27, 04103 Leipzig, Germany.

Erratum in

  • Br J Cancer 2002 Sep 9;87(6):689.

Abstract

Pancreatic ductal adenocarcinoma has a median survival of less than 6 months from diagnosis. This is due to the difficulty in early diagnosis, the aggressive biological behaviour of the tumour and a lack of effective therapies for advanced disease. Mammalian heparanase is a heparan-sulphate proteoglycan cleaving enzyme. It helps to degrade the extracellular matrix and basement membranes and is involved in angiogenesis. Degradation of extracellular matrix and basement membranes as well as angiogenesis are key conditions for tumour cell spreading. Therefore, we have analysed the expression of heparanase in human pancreatic cancer tissue and cell lines. Heparanase is expressed in cell lines derived from primary tumours as well as from metastatic sites. By immunohistochemical analysis, it is preferentially expressed at the invading edge of a tumour at both metastatic and primary tumour sites. There is a trend towards heparanase expression in metastasising tumours as compared to locally growing tumours. Postoperative survival correlates inversely with heparanase expression of the tumour reflected by a median survival of 34 and 17 month for heparanase negative and positive tumours, respectively. Our results suggest, that heparanase promotes cancer cell invasion in pancreatic carcinoma and could be used as a prognostic indicator for postoperative survival of patients.

Copyright 2002 Cancer Research UK

PMID:
11953884
[PubMed - indexed for MEDLINE]
PMCID:
PMC2375333
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk